These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7104274)

  • 1. Vitreous fluorophotometry in optic nerve disease.
    Braude LS; Cunha-Vaz JG; Frenkel M
    Br J Ophthalmol; 1982 Sep; 66(9):560-6. PubMed ID: 7104274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosing acute retrobulbar neuritis by vitreous fluorophotometry.
    Braude LS; Cunha-Vaz JG; Goldberg MF; Frenkel M; Hughes JR
    Am J Ophthalmol; 1981 Jun; 91(6):764-73. PubMed ID: 7246699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Axial and para-axial fluorophotometry in optic neuropathies].
    Szymański A; Gierek-Lapińska A; Koziak M
    Klin Oczna; 1996 Jan; 98(1):5-8. PubMed ID: 9019576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fluorescein glucuronide and its metabolism in vitreous fluorophotometry.
    Plehwe WE; Chahal PS; Fallon TJ; Cunningham JR; Neal MJ; Kohner EM
    Exp Eye Res; 1987 Feb; 44(2):209-15. PubMed ID: 3582508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreous fluorophotometry in juvenile-onset diabetes mellitus.
    Krupin T; Waltman SR; Oestrich C; Santiago J; Ratzan S; Kilo C; Becker B
    Arch Ophthalmol; 1978 May; 96(5):812-4. PubMed ID: 655917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic procedures in optic neuropathies].
    Hamard H
    Bull Soc Belge Ophtalmol; 1990; 236():11-20. PubMed ID: 2093404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vitreous detachment on vitreous fluorophotometry.
    Yoshida A; Furukawa H; Delori FC; Bursell SE; Trempe CL; McMeel JW
    Arch Ophthalmol; 1984 Jun; 102(6):857-60. PubMed ID: 6732564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control.
    White NH; Waltman SR; Krupin T; Santiago JV
    Diabetes; 1982 Jan; 31(1):80-5. PubMed ID: 6759217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The optic neuropathies].
    Biousse V
    Rev Neurol (Paris); 2005 May; 161(5):519-30. PubMed ID: 16106803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium-DTPA-enhanced magnetic resonance imaging in optic neuropathies.
    Guy J; Mancuso A; Quisling RG; Beck R; Moster M
    Ophthalmology; 1990 May; 97(5):592-9; discussion 599-600. PubMed ID: 2342804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axial and para-axial fluorophotometry in glaucoma simplex.
    Szymanski A; Gierek-Lapinska A; Koziak M; Gierek-Kalicka S
    Int Ophthalmol; 1992 Sep; 16(4-5):283-5. PubMed ID: 1428558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular fluorophotometry in the normal- and diabetic monkey.
    Jones CW; Cunha-Vaz JG; Zeimer RC; Rusin MM; Langenberg PW; Vygantas CM; Tso MO; Jonasson O
    Exp Eye Res; 1986 May; 42(5):467-77. PubMed ID: 3720865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences with fluorophotometry.
    Brooks AM
    Aust J Ophthalmol; 1982 Feb; 10(1):41-51. PubMed ID: 7103862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rupture of the hemato-ocular barrier, studied by fluorophotometry, in uveal melanoma patients. Preliminary results].
    Frau E; Gregoire-Cassoux N; Offret M; Labetoulle M; Nodarian M; Lautier-Frau M; Offret H
    J Fr Ophtalmol; 1998; 21(6):409-13. PubMed ID: 9759436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular fluorophotometry in normal subjects.
    Kjaergaard JJ
    Int J Microcirc Clin Exp; 1983; 2(3):199-205. PubMed ID: 6678847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Optic neuritis": a masquerading disease.
    Buyck A; Van Looveren I; Dralands L
    Bull Soc Belge Ophtalmol; 1990; 236():67-74. PubMed ID: 2093408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.
    Prager TC; Chu HH; Garcia CA; Anderson RE; Field JB; Orzeck EA; Comstock JP
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):57-65. PubMed ID: 6826315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked recessive retinitis pigmentosa and vitreous fluorophotometry. A study of female heterozygotes.
    Gieser DK; Fishman GA; Cunha-Vaz J
    Arch Ophthalmol; 1980 Feb; 98(2):307-10. PubMed ID: 7352882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent anterior ischemic optic neuropathy in young adults.
    Hamed LM; Purvin V; Rosenberg M
    J Clin Neuroophthalmol; 1988 Dec; 8(4):239-48. PubMed ID: 2977139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic interpretation of vitreous fluorophotometry.
    Zeimer RC; Blair NP; Cunha-Vaz JG
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1374-81. PubMed ID: 6618797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.